Skip to main content

Yun La Choi

Sungkyunkwan University · Medicine

About the Lab

Professor Yun La Choi's research lab specializes in molecular and immunohistochemical pathology, with a focus on identifying diagnostic and prognostic biomarkers in various cancers. The lab investigates molecular alterations in thyroid carcinomas, renal cell carcinomas, and lung cancers, emphasizing the role of key oncogenes such as MET, ALK, EGFR, and BRAF in tumorigenesis and treatment resistance. A central theme is the application of molecular diagnostics, including liquid biopsy and mutation detection in formalin-fixed paraffin-embedded tissues, to improve precision oncology. The lab also explores rare but diagnostically challenging conditions, such as gastric syphilis, highlighting the importance of histopathological awareness in differential diagnosis.

molecular diagnosticscancer biomarkersimmunohistochemistryliquid biopsytargeted therapy

Research Overview

Papers
24
Total Citations
94
Papers (5y)
9
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
9total
2016
2018
2019
2025
2026
Citations per year (5y)
15total
20162018201920252026

Selected Papers

15
1
Article|35 citations·2005
Immunoexpression of HBME-1,High Molecular Weight Cytokeratin, Cytokeratin 19,Thyroid Transcription Factor-1,and E-cadherin in Thyroid Carcinomas
최윤라, Mi Kyung Kim, Jin-Won Suh, 한정호, Jung Han Kim, 양정현, 남석진
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0191120050200050853

To examine the immunohistochemical alterations associated with the histological dedifferentiation of thyroid carcinomas, we performed staining for HBME-1, high molecular weight cytokeratin (HCK), CK 19, thyroid transcription factor-1 (TTF-1) and E-cadherin (E-CD) on 125 various types of thyroid carcinomas. The HBME-1 staining was strong and diffuse in follicular carcinoma (FC), papillary carcinoma (PC), and poorly differentiated carcinoma (PDC), while it was rare in undifferentiated carci-noma (

2
Article|30 citations·2006
MET Expression in Sporadic Renal Cell Carcinomas
Jong Sun Choi, Mi Kyung Kim, Jin Won Seo, 최윤라, 김동훈, Yi Kyeong Chun, 고영혜
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0191120060210040672

Although germline mutations of met proto-oncogene on human chromosome 7q31-34 have been known as useful molecular markers of hereditary papillary renal cell carcinoma (RCC), the expression of MET, a product of met proto-oncogene, has not been fully studied in sporadic RCC, along with its clinical significance. We inves-tigated the expression of MET by immunohistochemistry in 182 cases of renal neo-plasm encompassing 145 RCC, 25 urothelial carcinomas of renal pelvis, and 12 oncocytomas. MET was d

3
Review|9 citations·2019
Provisional Guideline Recommendation for EGFR Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group
Dong‐Hoon Shin, Hyo Sup Shim, Tae Jung Kim, Heae Surng Park, Yun La Choi, Wan Seop Kim, Lucia Kim, Sun Hee Chang, Joon Seon Song, Hyo Jin Kim, Jung Ho Han, Chang Hun Lee
SJR Q2Journal of Pathology and Translational MedicineOA

Liquid biopsy for detection of mutation from circulating tumor DNA is a new technology which is attractive in that it is non-invasive. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) is an effective first line drug for advanced non-small cell lung cancer patients who harbor activating EGFR mutation. During the course of treatment, resistance against TKI arises which can be contributed to EGFR T790M mutation in about 50-60% of patients. Third generation TKI may overcome t

Pulmonary and Respiratory MedicineMedicine
4
Article|6 citations·2018
Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors
심종민, 김현진, 현지연, 최윤라, 한정호

Background: Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) are usually effective in lung adenocarcinoma patients with anaplastic lymphoma kinase (ALK) rearrangement. However, even after a good response to ALK-TKI therapy, most patients acquire resistance to these agents. Histological transformation is one of several suggested mechanisms of acquired resistance to ALK-TKIs. The clinicopathologic features of four patients with ALK-expressing adenocarcinoma and neuroendocrine featu

5
Article|5 citations·2006
Gastric Syphilis Mimicking Adenocarcinoma: A Case Report
최윤라, 한재준, 이다근, 조민호, 권기영, 고영혜, 박철근, 안긍환
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0191120060210030559

Syphilis is an unexpected diagnosis in the stomach, and the reduced incidence of syphilis has made its clinical presentation less widely appreciated. We report a 43- yr-old man suffering from epigastric tenderness with an initial diagnosis of gastric carcinoma; gastric syphilis was confirmed by demonstrating spirochetes in a gas-tric biopsy specimen by silver impregnation. Excessive lymphoplasmacytic infiltra-tion with diffuse thickening of gastric rugae should raise suspicion of gastric syphili

6
Article|2 citations·2013
Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples
안수민, 장기택, 이지윤, 성지윤, 강소영, 하상윤, 최윤라, 김정선, 오영륜, 김경미

Background: Recently, BRAF inhibitors showed dramatic treatment outcomes in BRAF V600 mutant melanoma. Therefore, the accuracy of BRAF mutation test is critical. Methods: BRAF mutations were tested by dual-priming oligonucleotide-polymerase chain reaction (DPO-PCR), direct sequencing and subsequently retested with a real-time PCR assay, cobas 4800 V600 mutation test. In total, 64 tumors including 34 malignant melanomas and 16 papillary thyroid carcinomas were analyzed. DNA was extracted from for

7
Article|1 citations·2006
유방암 환자에서 수술 중 신속 면역조직화학 검사를 이용한 감시 림프절 생검
윤해란, 유기은, 최영진, 우상욱, 최윤라, 김정한, 남석진, 고영혜, 양정현

Purpose: The recently developed method of rapid immunohistochemistry (IHC) was applied to the intraoperative examination of sentinel lymph node (SLN) because as their routine frozen-section examination is liable to yield a false-negative results. This study is devoted to establish a reliable protocol for rapid IHC of SLN. Methods: Between August 2004 and April 2005 a retrospective study was performed. SLNs from 50 breast cancer patients with clinically negative SLN were examined intraoperativel

8
Article|1 citations·2013
Peripheral Primitive Neuroectodermal Tumor with Osseous Component of the Small Bowel Mesentery: A Case Study
김준미, 주영채, 최창환, 김루시아, 최석진, 박인서, 한지영, 김경래, 최윤라, 김태은
http://dx.doi.org/10.4132/KoreanJPathol.2013.47.1.77

A case of peripheral primitive neuroectodermal tumor of the small bowel mesentery with osseous component is reported. A 23-year-old man was admitted to our hospital because of acute severe abdominal pain. Abdominal computed tomography revealed a large solid and cystic, oval shaped mass, measuring 11.0×6.0 cm in the pelvic cavity. Histologically the resected lesion consisted of sheets of undifferentiated small round cells forming Homer-Wright rosettes and perivascular pseudorosettes, and showed a

9
Article|1 citations·2012
A Proposal for Creating a Guideline for Cancer Registration of the Fibromatosis, PEComa Group, Malignant Lymphoma In Situ and Dendritic Cell Tumors (III)
유창영, 손진희, 강창석, 최윤라, 강혜윤, 김진만, 고영혜, 이주희, 이승숙, 김인선, 김동훈, 박용구

Background: Understanding the biologic behavior of a tumor is a prerequisite for tumor registration code assignment. The aim of this report was to propose appropriate behavior codes of the International Classification of Disease Oncology 3 (ICD-O3) to rare, yet pathologically interesting hematopoietic and soft tissue tumors. Methods: The Study Group for Hematopathology, the Bone and Soft Tissue Pathology Study Group, and the Cancer Registration Committee prepared the questionnaire containing pro

10
Article|1 citations·2011
Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Manifested as a Soft Tissue Mass: Incidental Discovery on Histological Examination
하상윤, 최윤라, 김성주, 고영혜

We report an extraordinary case of diffuse large B-cell lymphoma arising in a cystic necrotic mass in a 35-year-old man who presented with a soft tissue mass at the site of previous surgery. A benign mass was surgically removed 17 years ago, after which a cystic lesion gradually developed at the same site. The resected mass appeared as a thick-walled cyst filled with brown necrotic and hemorrhagic material. On microscopic examination, the cyst wall was primarily necrotic tissue with some aggrega

11
Article|1 citations·2011
Effects of Low and High Molecular Weight Hyaluronic Acids on Peridural Fibrosis and Inflammation in Lumbar Laminectomized Rats
Jun Geol Lee, 심우석, 이상철, 김용철, 임영진, Jae Hyuck Shin, Jae Hun Kim, 박상현, 최윤라

Background:Postlaminectomy peridural fibrosis is inevitable. Some studies have compared and identified the effects of high molecular weight hyaluronic acids (HMWHA) and low molecular weight hyaluronic acids (LMWHA) on peridural fibrosis in postlaminectomy animal models. However, no studies have been found that compare pain behaviors between hyaluronic acids or among hyaluronic acids and other solid materials. The purpose of this study was to examine the correlation between pain-related behaviors

12
Article|1 citations·2012
한국인 갑상선 여포종양의 RAS 변이와 PAX8/PPARγ 재배열의 빈도
김혜정, 장혜원, 손서영, 최윤라, 김희진, 오영륜, 김선욱, 정재훈

Background: Follicular thyroid tumors harbor several genetic alterations such as RAS mutations and PAX8/PPARγ rearrangement. The aims of our study were to investigate the prevalence of RAS mutations and PAX8/PPARγ rearrangement in follicular thyroid tumors and to correlate RAS mutations and/or PAX8/PPARγ rearrangement with clinicopathologic features in Korean patients with follicular thyroid carcinomas. Methods: RAS mutations were investigated by polymerase chain reaction and DNA sequencing in s

13
Article|1 citations·2006
원발성 유방암 환자의 감시림프절 생검상 미세전이와 거대전이가 있는 경우의 임상적 비교
유기은, 최영진, 최윤라, 김정한, 남석진, 양정현

Purpose: The aim of this study was to compare the micrometastasis group with the macrometastasis group, and to analyze clinical and pathological variables to determine what factors might predict non-sentinel lymph node (NSLN) involvement in the women with sentinel nodes that contained only micrometastasis. Methods: Between June 2003 and September 2005, 650 patients with primary breast cancer and who underwent a SLN procedure were retrospectively reviewed. Of those 650 patients, 138 patients wit

14
Article|0 citations·2026
Abstract 5554: Anti-human CTLA-4×TIGIT bispecific antibody: A novel immunotherapy specifically targeting tumor-infiltrating FOXP3+ regulatory T cells
Soojin Ryu, Hee Geon Park, Sang Beom Bang, Ji Hye Nam, Ho Jin Lee, Ju Yeon Seo, Gun Yi Ahn, Myeung Ryun Seo, Sang Moo Lee, Yun La Choi, S.K. Hong, Young Kee Shin
SJR Q1Cancer Research

Abstract Background: Regulatory T cells (Tregs) are key drivers of immune suppression within the tumor microenvironment (TME). In multiple cancer types, increased numbers of Tregs are associated with poor prognosis in terms of both disease progression and patient survival. This includes lung, breast, pancreatic, hepatocellular, renal, gastric, and cervical cancers. Specifically, the subset of Forkhead box P3 (FOXP3)+ effector Tregs, distinguished by increased expression of immune checkpoint mole

OncologyMedicine
15
Article|0 citations·2016
Successful Treatment with Empirical Erlotinib in a Patient with Respiratory Failure Caused by Extensive Lung Adenocarcinoma
정석현, 엄상원, 이현, 전경만, 이경종, 서지영, 정만표, 김호중, 권오정, 최윤라

We herein describe a 70-year-old woman who presented with respiratory failure due to extensive lung adenocarcinoma. Despite advanced disease, care in the intensive care unit with ventilator support was performed because she was a newly diagnosed patient and was considered to have the potential to recover after cancer treatment. Because prompt control of the cancer was needed to treat the respiratory failure, empirical treatment with an oral epidermal growth factor receptor (EGFR) tyrosine kinase

Research Areas

Pulmonary and Respiratory MedicineOncology

Dive deeper into Yun La Choi's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.